New cancer therapies in 2022 achieving unprecedented remissions - reviewing a year of hope
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
Join the club for FREE to access the whole archive and other member benefits.
This section will maintain key information and medical advancements relating to cancer – how to prevent it and what treatments are available.
Not every new story - just major breakthroughs and studies on ways to prevent. Particularly will be focusing on research results in humans - lots of promising treatments unfortunately never make it from the lab, through human trials, and onto the market.
Did you know? A handful of your cells turn cancerous EVERY DAY - but your immune system tracks them down and kills them before they turn into large-scale cancer.
Click on resource name for more details.
Biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Company that target cancer by developing senescence inducing and senolytic (senescent cell killing) compounds.
Institute researching and developing drug discovery in the fields of cancer and inflammation
DNA nanobots will soon be tried in a critically ill leukemia patient
Company that develops a technology platform to improve the cancer drug development process
Including gene editing, immunotherapy, modified viruses, vaccines, personalised medicine, and nanotechnology
Provides an early warning or peace of mind – good value for money either way
The Guardian - 03-Jan-2023
Getting diagnosis within seconds could enable women confirmed to have cancer start treatment sooner
Read more...BBC - 11-Dec-2022
Base editing can soon be a part in taking control of our genomes to fight genetic diseases
Read more...EurekAlert! - 10-Nov-2022
Mutations in a telomere binding protein provide a new approach to treat melanoma and other cancers
Read more...BBC - 10-Sep-2022
Mutations alone are not always enough for tumour formation
Read more...Pharmashots - 10-Aug-2022
NBTXR3 might give hope to patients who are ineligible for certain chemotheraphy
Read more...